[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
Sixteen patients, 9 to 81 years old, with Gram-negative septicaemia have been treated with cefotaxime. In all cases, the patients were hospitalised in an intensive care unit for a severe infection distinct from septicaemia. Cefotaxime was given alone to 11 patients and was administered by infusion over 20 to 30 minutes, every 4 or 6 hours, in a daily dose of 67 to 94 mg/kg to patients with normal of subnormal renal function. Gram-negative pathogens were sensitive to cefotaxime (MIC less than 1 mcg/ml in most cases). A clinical cure was obtained in 14 patients. In all the cases, tolerance was good. The very low MIC's of cefotaxime and the results in severe Gram-negative septicaemia justify the use of cefotaxime in monotherapy, in patients with severe life-threatening infections, when blood cultures appear to be positive for Gram-negative pathogens, even without awaiting antibiograms.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002439:Cefotaxime; D002511:Cephalosporins / Q000097:blood / Q000627:therapeutic use*; D002648:Child; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D018805:Sepsis / Q000188:drug therapy*
D002511:Cephalosporins; D002439:Cefotaxime
Traitement des septicémies à bacilles à Gram négatif par le céfotaxime. 16 observations.